Vaginal Isonicotinic Acid Hydrazide Prior to Diagnostic Office Hysteroscopy in Primarily Infertile Patients
Status:
Completed
Trial end date:
2021-09-15
Target enrollment:
Participant gender:
Summary
To compare the effectiveness of vaginal isonicotinic acid hydrazide with placebo in
minimizing the pain experienced by primarily infertile patients during diagnostic office
hysteroscopy and to assess the ease of insertion of hysteroscope as reported by the
hysteroscopist.